Article
Canaccord Genuity Upgrades Doximity to Buy, Lowers Price Target to $34
Canaccord Genuity analyst Richard Close upgrades Doximity (NYSE:DOCS) from Hold to Buy and lowers the price target from $48 to $34.
Comments
- No comments yet. Be the first to comment!